# Aspira Women's Health Inc. (AWHL) — management_change/ceo [announced]
Source: SEC API (secapi.ai) · situation sit_cd3a157dbe13aa0e7101 · retrieved 2026-08-11T15:50:51.204Z

## Overview
Aspira Women's Health Inc. is an in vitro and in vivo diagnostic company that develops diagnostic substances and tests.

On June 27, 2026, Aspira Women's Health Inc. and former Chief Executive Officer Michael Buhle entered into a Separation Agreement and General Release, which became effective on or about July 6, 2026, following a seven-day revocation period. Under the agreement, the Company will pay Mr. Buhle cash severance of $200,000 (representing six months of base salary), payable in substantially equal installments beginning on the first payroll date following the Effective Date. The Company will also pay COBRA premiums for Mr. Buhle and his eligible dependents for six months following the June 17, 2026 separation date. Subject to Compensation Committee approval, the Company will accelerate vesting of 64,583 stock options at an exercise price of $0.07 per share, exercisable for 90 days following the Effective Date, subject to share restrictions including a 90-day lock-up period, a daily volume limit of 2,500 shares, a price floor of $0.45 per share, and sales only through an approved broker-dealer.

## Terms
- Counterparty: Michael Buhle · Deal value: $200,000 · Consideration: cash · Price/share: $0.07

## Key dates
- Announced 2026-07-07 · Expected close 2026-07-06

## Timeline
- 2026-07-07 · 8-K/A (0000926617-26-000050): 8-K/A - Aspira Women's Health Inc. — *Aspira Women's Health Inc. is an in vitro and in vivo diagnostic company that develops diagnostic substances and tests.* On June 27, 2026, Aspira Women's Health Inc. and former Chief Executive Officer Michael Buhle entered into a Separation Agreement and General Release, which became effective on or about July 6, 2026, following a seven-day revocation period. Under the agreement, the Company will pay Mr. Buhle cash severance of $200,000 (representing six months of base salary), payable in substantially equal installments beginning on the first payroll date following the Effective Date. The Company will also pay COBRA premiums for Mr. Buhle and his eligible dependents for six months following the June 17, 2026 separation date. Subject to Compensation Committee approval, the Company will accelerate vesting of 64,583 stock options at an exercise price of $0.07 per share, exercisable for 90 days following the Effective Date, subject to share restrictions including a 90-day lock-up period, a daily volume limit of 2,500 shares, a price floor of $0.45 per share, and sales only through an approved broker-dealer.
  https://www.sec.gov/Archives/edgar/data/926617/0000926617-26-000050.txt

## Citations
- 0000926617-26-000050 — https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&type=&dateb=&owner=include&count=40&search_text=000092661726000050